Bixiye
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat)
Taariikhda dhaqangalka Barnaamijka: Jul 13, 2022
Natiijooyinka Raadinta
Soo bandhiga 1611 - 1620 ee natiijooyinka 4139
Macluumaadka Maaliyadda
Bixiye
commercial-general-coding-073-clinical-trial.pdf
Macluumaadka Maaliyadda
Bixiye
medicare-general-coding-009-maximum-units-per-day.pdf
Macluumaadka Maaliyadda
Bixiye
medicare-general-coding-079-hair-removal-for-gender-affirming-procedures.pdf
Macluumaadka Maaliyadda
Bixiye
commercial-labpath-001-laboratory-rebundling-services.pdf
Macluumaadka Maaliyadda
Bixiye
commercial-em-012-consultation-services.pdf
Bixiye
P46-23 Services Removed from the Commercial Prior Authorization List
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P36-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P37-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective July 31, 2023
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023